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ORIGINAL ARTICLE
Osteoinductive PolyHIPE Foams as Injectable Bone Grafts
Jennifer L. Robinson, PhD,1 Madison A.P. McEnery, BS,1 Hannah Pearce,1
Michael E. Whitely, BS,1 Dany J. Munoz-Pinto, PhD,2 Mariah S. Hahn, PhD,2 Huinan Li, BS,3
Nicholas A. Sears, MS,1 and Elizabeth Cosgriff-Hernandez, PhD1
We have recently fabricated biodegradable polyHIPEs as injectable bone grafts and characterized the mechanical
properties, pore architecture, and cure rates. In this study, calcium phosphate nanoparticles and demineralized
bone matrix (DBM) particles were incorporated into injectable polyHIPE foams to promote osteoblastic differ-
entiation of mesenchymal stem cells (MSCs). Upon incorporation of each type of particle, stable monoliths were
formed with compressive properties comparable to control polyHIPEs. Pore size quantification indicated a neg-
ligible effect of all particles on emulsion stability and resulting pore architecture. Alizarin red calcium staining
illustrated the incorporation of calcium phosphate particles at the pore surface, while picrosirius red collagen
staining illustrated collagen-rich DBM particles within the monoliths. Osteoinductive particles had a negligible
effect on the compressivemodulus (*30MPa), which remained comparable to human cancellous bone values. All
polyHIPE compositions promoted humanMSC viability (*90%) through 2 weeks. Furthermore, gene expression
analysis indicated the ability of all polyHIPE compositions to promote osteogenic differentiation through the
upregulation of bone-specific markers compared to a time zero control. These findings illustrate the potential for
these osteoinductive polyHIPEs to promote osteogenesis and validate future in vivo evaluation. Overall, this work
demonstrates the ability to incorporate a range of bioactive components into propylene fumarate dimethacrylate-
based injectable polyHIPEs to increase cellular interactions and direct specific behavior without compromising
scaffold architecture and resulting properties for various tissue engineering applications.
Introduction
T issue engineered bone grafts combine the healingpotential of autografts with the availability of alloplasts
to better promote regeneration for patients with a variety of
injuries, healing rates, and overall health. Polymerization of
high internal phase emulsions (polyHIPEs) is a relatively
new method for the production of high porosity scaf-
folds. Altering compositional and processing parameters
results in monoliths with a range of pore sizes, porosities,
pore morphologies (open vs. closed), compressive proper-
ties, and cure times.1–11 However, a major challenge in de-
signing functional bone grafts is determining a material
composition that promotes ingrowth of surrounding bone
and proliferation of cells (osteoconduction), the differenti-
ation of progenitor cells down an osteoblastic lineage (os-
teoinduction), and osseointegration with the native bone.
Various scaffold chemistries and bioactive agents are cur-
rently being studied to determine a matrix that presents cues
to stimulate osteoblastic differentiation of human mesen-
chymal stem cells (hMSCs) and promote integration and
healing. Extensive research has focused on recombinant
growth factors, such as bonemorphogenetic proteins (BMPs),
for effective osteoblastic differentiation of hMSCs. While
these factors are excellent at stimulating osteogenesis, recent
clinical studies have reported complications such as ectopic
bone formation and inflammation-related fatalities.12,13 In
contrast, natural components of bone such as inorganic
minerals and matrix proteins have been shown to induce os-
teogenic differentiation without the undesired side effects of
growth factors.14–16
Calcium phosphates (CaP) comprise the primary mineral
component of native bone and are commonly utilized in bone
tissue engineering to promote osteogenesis. Based on Ca/P
ratio, crystallinity, and degree of impurities, a range of
bioactivities and degradation rates are achieved with calcium
phosphates.17–21 Hydroxyapatite (HA) has also been utilized
extensively in biomaterial research illustrating the potential
for calcium phosphates to promote osteogenesis in vitro.
However, at physiological pH, highly crystalline HA exhibits
poor solubility and hinders desired cell responses due to low
concentrations of calcium and phosphate ions released.22
Amorphous calcium phosphate lacks any crystal structure
and is resorbed more readily than crystalline HA.23 For this
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reason, many researchers have investigated the resorption
rates of mixed calcium phosphate compositions with differ-
ent percent crystallinities and assessed the effect on in vivo
bone regeneration.24,25 The relative ability of these calcium
phosphate minerals to stimulate progenitor cell proliferation
and differentiation is dependent on the physiological envi-
ronment and presentation in the scaffold. In contrast, the
demineralized bonematrix (DBM) stimulates bone growth by
providing an environment in which invading progenitor and
inflammatory cells are stimulated to release trophic cytokines
to recruit cells for repair.26 It has been hypothesized that the
demineralization process exposes growth factors and other
bioactive molecules, which would otherwise remain inactive
in the presence of minerals.26,27 Work by Pietrzak demon-
strated that inorganic minerals reduced hydration of the or-
ganic matrix limiting the solubility and thereby bioactivity of
growth factors such as BMPs.28 All three of these bioactive
particles have been investigated as potential bone graft ad-
ditives to confer osteoinductive character to a variety of
scaffolds.
A unique attribute of the HIPE system is the ability to
introduce small particles that can self-assemble at the pore
surface due to their size and surface charge. Emulsions sta-
bilized by solid particles, which adsorb to the oil–water in-
terface rather than a molecular surfactant, are termed as
Pickering emulsions.29 Multiple groups have successfully
fabricated and characterized water-in-oil (w/o) Pickering
polyHIPEs utilizing both titania and silica nanoparticles.30–33
The preferential location of self-assembled particles at the
pore wall potentially provides a bioactive component for
direct contact with encapsulated MSCs for signaling to pro-
mote osteoblast differentiation. Furthermore, this methodol-
ogy promotes the ability to use less of the expensive bioactive
particles and still achieve the desired cellular response due to
the presentation of the particles at the polyHIPE pore walls.
Incorporating both calcium phosphate and DBM into in-
jectable polyHIPEs may provide a rigid foam capable of
promoting viability, proliferation, and material-based osteo-
genesis of hMSCs.
A small number of studies have demonstrated the potential
of HA modification of polyHIPE monoliths to guide cellular
behavior. Bokhari et al. incorporated HA into styrene–
divinylbenzene polyHIPEs and illustrated the ability to
increase the production of bone matrix glycoprotein osteo-
pontin (OPN) and mineral deposition relative to control
specimens.34 In this work, the HA was added to the aqueous
phase rather than the organic phase and thereby relied on
adsorption onto the polymer struts for maintenance within the
polyHIPE. This weak interaction reduces the effective con-
centration of particles actually at the pore wall surface over
time. Zhou et al. reported on pickering biopolymer emulsions
stabilized with 1–4wt% HA particles incorporated into the
organic phase that resulted in stable monoliths with 1–50mm
pore sizes.35 However, these were noninjectable hydrogel
grafts with insufficient mechanical properties to withstand
physiological loading as a bone graft. A recent study of
pickering polyHIPEs fabricated with poly(lactic acid)-
grafted HA nanoparticles as the stabilizer in poly(lactic-
co-glycolic acid) w/o emulsions showed tunable pore
architecture, enhanced mineralization potential, and murine
MSC viability as a function of grafted HA concentration.36
These collective results are promising for use of this emul-
sion templating technique to fabricate porous materials that
promote the desired cell behavior. However, all of this work
was conducted on prefabricated monoliths, and the use of
nondegradable macromers, poor mechanical properties, toxic
diluents, or supraphysiological temperatures precludes their
use as injectable bone grafts.
Previously, our laboratory has demonstrated the fabrica-
tion of injectable biodegradable polyHIPEs without the need
for a toxic diluent and with rapid cure rates at physiological
temperature.7,8,37 This platform technology provides a tun-
able system for fabricating high porosity scaffolds with
properties comparable to the trabecular bone that can be used
to fill irregularly shaped defects directly in the surgical suite
without the need for prefabrication based on computer-aided
design. The present study expands upon our injectable
polyHIPE platform technology to fabricate monoliths with
osteoinductive character to promote osteogenesis and inte-
gration. To this end, amorphous calcium phosphate nano-
particles, HA nanoparticles, and DBM particles were added
to the organic phase before fabrication to increase hMSC
proliferation and osteogenic potential. Redox-cured poly-
HIPEs promoted incorporation of particles with a range of
hydrophobicities and surface charge due to the quick set
times that reduced time allowed for phase separation. The
ability to incorporate bioactive particles into the HIPE
without affecting emulsion stability and resulting pore ar-
chitecture was investigated using scanning electron micros-
copy (SEM). The effect of each osteoinductive agent on the
compressive properties of propylene fumarate dimethacry-
late (PFDMA)-based polyHIPEs was evaluated. Transmis-
sion electron microscopy (TEM) techniques and alizarin red
calcium staining were used to illustrate the location of the
nanoparticles at the pore surface. Finally, the ability of these
particles to promote hMSC differentiation in vitro was as-
sessed by quantifying the upregulation of RNA coding for the
osteoblast-specific markers runt-related transcription factor 2
(runx2), alkaline phosphatase (ALP), osteopontin (OPN),
collagen type I (Col1a1), and osteocalcin (OCN). Overall,
this work highlights the potential of this injectable polyHIPE
system to be fabricated with osteoinductive particles to pro-
mote osteoblastic differentiation of hMSCs and emphasizes
the potential of the polyHIPE scaffold technology to enhance
bone regeneration.
Materials and Methods
Materials
Polyglycerol polyricinoleate (PGPR 4125) was provided
by Palsgaard. hMSCs were provided by the Texas A&M
Health Science Center College of Medicine Institute for
Regenerative Medicine at Scott & White through a grant
from NCRR of the NIH (Grant No. P40RR017447). All other
chemicals were purchased and used as received from Sigma
Aldrich unless otherwise noted.
Demineralization and homogenization
of rat long bones
Euthanized Sprague Dawley rats were obtained from the
tissue share program at the Laboratory Animal Research and
Resources facility at Texas A&M University. The deminer-
alization process was adapted from Figueiredo et al.38 Long
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hind bones were extracted from the rats, rid of soft tissue
using a scalpel and gauze, and the majority of marrow re-
moved with water and compressed air. Bones were soaked in
a 1:1 volume chloroform: methanol solution at 1 g bone to
30mL solution for 3 h. After solvent treatment, bones were
washed once with reverse osmosis water, placed in a 0.6M
HCl solution, and stirred for 24 h to decalcify. Residual HCl
was then removed by rinsing with water, stirring DBM in
freezing water, and placed under vacuum at 40C overnight.
DBMwas then blended into smaller pieces and homogenized
into particles using a handheld digital homogenizer (IKA T25
digital ULTRA-TURRAX). SEM was utilized to determine
relative particle sizes. Visual assessment of micrographs
determined particle sizes ranging from 50 to 200mm.
Macromer synthesis and purification
PFDMA was synthesized and purified in a two-step pro-
cess detailed in our earlier work.8 Briefly, the diester 1,2
hydroxypropyl fumarate was synthesized by adding propyl-
ene oxide dropwise to a solution of fumaric acid and pyridine
in 2-butanone (2.3:1.0:0.033mol) and refluxing at 75C for
18 h. Residual reagents were removed by distillation, and the
product redissolved in dichloromethane before removing
acidic byproducts with washing. The diester product was then
dried under vacuum before endcapping with methacrylate
groups using methacryloyl chloride in the presence of trie-
thylamine. The molar ratios of the diester, methacryloyl
chloride, triethylamine were 1:2.1:2.1, respectively. Hydro-
quinone was added to the diester to inhibit crosslinking
during synthesis at a molar ratio of 0.008:1. The reaction was
maintained below -10C to reduce undesirable side reactions
and stirred vigorously under a nitrogen blanket. The macro-
mer was neutralized overnight with 2M potassium carbonate
and residual base removed with an aluminum oxide column
(7 Al2O3:1 TEA). The integration ratio of methacrylate
protons to fumarate protons in the 1H NMR spectra was used
to confirm >85% functionalization for all macromers before
polyHIPE fabrication. (300MHz, CdCl3) d 1.33 (dd, 3H,
CH3), 1.92 (s, 3H, CH3), 4.20 (m, 2H, eCH2e), 5.30 (m, 1H,
eCHe), 5.58 (s, 1H,eC]CH2), 6.10 (s, 1H,eC]CH2), 6.84
(m, 2H, eCH]CHe). Butanediol dimethacrylate (BDMA)
was passed through a column containing alumina oxide using
high air pressure to remove the monomethyl ether hydroqui-
none inhibitor and collected in a round bottom flask. The
purified products were stored at 4C under a nitrogen blanket
until used for HIPE fabrication.
PolyHIPE fabrication
Quick-curing redox polyHIPEs were fabricated utilizing a
FlackTek SpeedMixer DAC 150 FVZ-K following the
method developed in our laboratory.37 A 70:30 molar ratio of
PFDMA:BDMA was utilized to ensure an adequate viscosity
to mix with a cell suspension in future studies. Previous
studies investigating the cytocompatibility of all polyHIPE
components have illustrated good hMSC viability (>85%) at
72 h. The organic phase further comprised 10wt% PGPR and
1wt% benzoyl peroxide (BPO) initiator or trimethylaniline
(TMA) reducing agent. For osteoinductive polyHIPEs,
2wt% amorphous calcium phosphate (ACP) nanoparticles
(<150 nm nanopowder; Sigma), 5wt% HA nanoparticles
(HA, <200 nm nanopowder; Sigma), or 15wt% DBM was
added to the organic phase. These concentrations reflect the
maximum concentration of osteoinductive components that
promoted stable HIPE formation. HA and ACP were selected
to assess the effect of crystallinity and rate of dissolution on
osteogenic differentiation. Previous studies have reported a
significant increase in calcium ion release and subsequent
osteoclast-mediated resorption rate and new bone forma-
tion in response to scaffolds containing ACP compared to
HA.24,25 The aqueous solution of calcium chloride (1wt%)
and deionized water was then added to the organic phase
(75% v) in six additions and mixed at 500 rpm for 2.5min
each to promote emulsification. The two HIPEs (BPO and
TMA) were mixed at 2500 rpm for 30 s in the SpeedMixer to
initiate crosslinking. HIPEs were transferred to either 2-mL
microcentrifuge tubes or 15-mL centrifuge tubes and placed
in a 37C aluminum bead bath to facilitate crosslinking
overnight.
Pore size characterization
SEM (Phenom Pro; Nanoscience Instruments) was utilized
to image all polyHIPEs and determine the effect of the in-
corporation of osteogenic particles on polyHIPE pore sizes.
PolyHIPEs were subjected to vacuum drying for 72 h to re-
move water before pore architecture characterization. Poly-
HIPEs cured in 15-mL centrifuge tubes (n = 3) were sectioned
into thirds, fractured at the center, coated with gold, and
imaged in a rastor pattern yielding five images for each of the
nine specimens per composition. Pore size measurements
were completed on the first 10 pores that crossed the median
of each 4000·magnification micrograph. Average pore sizes
for each polyHIPE composition are reported (n = 450). A
statistical correction was calculated to account for nonperfect
spherical pores, h2 =R2 - r2, where R is the void diameter’s
equatorial value, r is the diameter value measured from the
micrograph, and h is the distance from the center. The av-
erage diameter values were multiplied by this correction
factor, resulting in a more accurate description of pore di-
ameter.39
Compressive testing
The effect of each osteoinductive agent on the polyHIPE
compressive modulus and strength was investigated follow-
ing ASTM D1621-04a. PolyHIPEs cured in 15-mL centri-
fuge tubes were sectioned into disks with a 3:1 diameter to
height ratio using an IsoMet saw (Buehler) and compressed
using an Instron 3300 at a strain rate of 50mm/s. The com-
pressive modulus was calculated from the slope of the linear
region, and the compressive strength was identified, after
correcting to zero strain, as the stress at the yield point or 10%
strain, whichever point occurred first. Reported moduli and
strength data were averages of three specimens for each
polyHIPE composition.
Alizarin red staining of ACP and HA in polyHIPE
Alizarin red binds to calcium ions and was utilized to vi-
sually verify the incorporation of calcium phosphate particles
in PFDMA/BDMA films and polyHIPEs. In addition, poly-
HIPEs were stained after culture in growth media (16.5%
fetal bovine serum; Atlanta Biologicals, Premium Select, Lot
No. B13018) and 1% L-glutamine (Life Technologies) in
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Minimum Essential Media-a (MEM-a; Life Technologies)
to assess potential calcium deposition from the media after 1
and 2 weeks. PolyHIPEs of each condition were sectioned to
1mm width specimens using an IsoMet saw (Buehler).
Specimens were incubated for 5min in 2 w/v% alizarin red in
distilled water solution, pH 4.1–4.3. Stained specimens were
washed with distilled water 5· to remove any unreacted dye
and staining captured with digital micrographs.
Picrosirius red staining of DBM in polyHIPE
Picrosirius red, which stains collagen, was used to both
verify that the DBM extraction procedure resulted in a
collagen-rich matrix and illustrate the incorporation of DBM
in the polyHIPEs. A 1mg/mL solution of picrosirius red was
added to specimens and incubated at room temperature for
30min. Type I rat tail collagen (Sigma) was utilized as a
positive control for the stain. Following staining, specimens
(n = 3) were rinsed with deionized water 5· and imaged with
a digital camera.
TEM of polyHIPEs
TEM was utilized to identify the location of calcium
phosphate nanoparticles in the HIPEs. PolyHIPEs were first
fixed with 3% glutaraldehyde (Electron Microscopy Science)
for 15min followed by fixation for 30min with a 1% osmium
tetraoxide in deionized water on an orbital shaker. After a
successive gradient of ethanol dehydration, polyHIPEs
samples were infiltrated with an Eponate 12 resin (Ted Pella)
on a rotator overnight. Infiltrated samples were then put in a
vacuum oven for polymerization. An ultramicrotome (Du-
pont Instrument; Sorvell, MT2-B) was utilized to make
70 nm sections that were then placed on a copper grid coated
with polyetherimide on both sides. Before imaging, grids
were stained with saturated uranyl acetate (Ted Pella) and
washed with deionized water. The slot grid was imaged with
a JEOL 1200 ( Jeol Ltd.) operated at 100 kV. Micrographs
were collected at 10,000·, 20,000·, and 30,000· magnifi-
cations on a bottom-mounted, 9 MP, slow scan, lens-coupled
CCD camera SIA 15C (SIA).
hMSC viability and proliferation on polyHIPEs
with ACP, HA, and DBM
Investigation of hMSC viability was conducted to assess
cell response to injectable PFDMA-based polyHIPEs with
osteoinductive particles. Bone marrow-derived hMSCs were
obtained as passage 1 in a cryovial from the Center for the
Preparation and Distribution of Adult Stem Cells. Cells were
cultured in growth media containing 16.5% fetal bovine se-
rum, 1% L-glutamine, and MEM-a to 80% confluency and
utilized at passage 3. For these studies, polyHIPEs were cured
in 2-mL microcentrifuge tubes, sectioned into 500mm thick
wafers using the IsoMet saw, and cut to 8mm diameter with
a biopsy punch. For all in vitro studies, polyHIPE wafers
were weighed down in the 48-well plate utilizing hollow
Teflon weights. Specimens were sterilized for 3 h in 70%
ethanol, washed four times with phosphate-buffered saline
(PBS), and incubated overnight in basal media supplemented
with 40w/v% FBS at 5%CO2, 37C. Cells seeded at a density
of 100,000 cells/cm2 onto the polyHIPE sections in growth
media supplemented with 1% penicillin/streptomycin (Life
Technologies). Viability at 1 and 2 weeks was assessed uti-
lizing the LIVE/DEAD Assay Kit (Molecular Probes) ac-
cording to manufacturer’s instructions. Briefly, cells were
washed with PBS, stained with 2 mM calcein and 2mM
ethidium homodimer-1 for 30min in 37C, and replaced with
PBS for imaging. Rastor imaging (five images per specimen)
was conducted on four specimens (n = 20) utilizing a fluo-
rescence microscope (Nikon Eclipse TE2000-S). A Quant-
iT PicoGreen dsDNA Assay Kit (Molecular Probes) was
utilized to quantify dsDNA to determine the effect of parti-
cles on hMSC proliferation at 1 and 2 weeks relative to day 1.
PolyHIPE sections were removed from the culture wells and
placed in unused wells for the lysis procedure before the
PicoGreen assay to ensure only DNA from cells adhered onto
the scaffolds was measured. Fluorescence intensity was as-
sessed using a plate reader (Tecan Infinite M200Pro) with
excitation/emission wavelengths of 480/520 nm, respec-
tively. Average cell numbers were determined by converting
dsDNA values to an individual cell number using 6.9 pg
DNA/cell.40
Gene expression of bone-specific markers
Osteogenic progression of hMSCs at 1 and 2 weeks was
evaluated by quantitative real-time polymerase chain reaction
(qRT-PCR) relative to day 0. PolyHIPEs with no particles,
2wt% ACP, and 5wt% HA were evaluated with hMSCs cul-
tured in growthmedia. The goal of this study was to determine
the maximum osteogenic response achieved through poly-
HIPEs fabricated with ACP and HA nanoparticles. Therefore,
the concentrations of nanopowders reflect the maximum con-
centration of osteoinductive components that promoted stable
HIPE formation. No particle polyHIPEs with hMSCs cultured
in osteogenic media (growth media supplemented with 10nM
dexamethasone, 20 nM b-glycerol phosphate, and 50mM L-
ascorbic acid 2 phosphate) were run to compare the effects of
soluble cues in the media with material cues. Gene expression
was not evaluated on specimens with 15wt% DBM in this
study. Specifically, gene expression for runx2, ALP, OPN,
Col1a1, and OCN was quantified relative to the housekeeping
gene b-actin. In brief, mRNA was extracted using the Dyna-
beads mRNA DIRECT Kit (Ambion, Life Technologies) ac-
cording to the method described byMunoz-Pinto et al.41 Each
polyHIPE specimen was rinsed with 250mL DPBS for 5min.
Thereafter, 250mL of the provided lysis binding buffer was
added over the sample and incubated at room temperature for
10min. Following incubation, the polyA-mRNA in the extract
was harvested using 20mL of Dynabeads oligo (dT)25 mag-
netic beads. Directly after the rinsing steps, the polyA-mRNA
was released from the Dynabeads in 100mL of 10mM Tris-
HCl by heating the beads to 80C for 2min. Purified mRNA
was then stored at -80C until further analysis.
Proprietary qRT-PCR verified primers for human runx2,
OPN, and b-actin were purchased from OriGene and ALP,
Col1a1, and OCN were purchased from Qiagen. qRT-PCR
was performed on each sample using a StepOne Real-Time
PCR system (Life Technologies) and the SuperScript III
Platinum One-Step qRT-PCR Kit (Invitrogen, Life Tech-
nologies). mRNA levels for each gene of interest were as-
sessed in duplicate for each sample. A total of *25 ng of
polyA-mRNA was loaded per 25mL of reaction mixture at a
total primer concentration of 200 nM. Expression of each
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gene of interest was calculated relative to b-actin using the
DDCt method and following the analysis described by
Munoz-Pinto et al.41
Statistical analysis
All data are displayed as mean – standard deviation for
each composition. A Student’s t-test was performed on the
compressive, viability, and proliferation data to determine
any statistically significant differences between compositions
at the respective time points. An ANOVA test with Tukey’s
HSD post hoc analysis was conducted on the gene expression
data. For the compression and viability studies, tests were
carried out at a 99% confidence interval ( p< 0.01), whereas
the proliferation and gene expression tests were conducted at
a 95% confidence interval ( p< 0.05).
Results and Discussions
Incorporating CaP and DBM particles into polyHIPEs
This work focused on the self-assembly of osteoinductive
particles at the polyHIPE pore wall to promote material-
based osteogenesis and mitigate many of the risks associ-
ated with release of potent growth factors. Self-assembly at
the interface allows for surface enrichment of nanoparticle
additives at the pore wall, which is vital in ensuring
encapsulated hMSCs interact with the bioactive agents.
Surface enrichment also permits the use of reduced con-
centrations and minimizes the impact on bulk properties.
Initial scoutings were done to determine the maximum
concentration of each osteogenic element that promoted
stable HIPE fabrication. PolyHIPEs with a 70:30 molar ratio
of PFDMA:BDMA were fabricated with the osteogenic
components. This macromer composition was chosen based
on its viscosity, which promotes mixing with aqueous so-
lutions for future cell encapsulation studies. Redox-cured
polyHIPEs that exhibit quick set times allowed for incor-
poration of particles with a range of hydrophobicities and
surface charge by reducing the time allowed for phase
separation. Concentrations of 2 wt% ACP, 5 wt% HA, and
15wt% DBMwere the maximum that could be incorporated
without substantial phase separation and were the amounts
utilized for the remainder of studies.
TEM imaging and colorimetric staining were conducted to
verify the presence of the particles at the surface of the poly-
HIPE sections to ensure direct contact with encapsulated
hMSCs. Figure 1 shows representativemicrographs of a 5wt%
HA polyHIPE section compared to no particle control. Single
nanoparticles are seen self-assembled at the pore surface and
aggregated particles are located in the pore wall. This differing
behavior is most likely due to the relatively broad size range of
the commercial HA nanoparticles (1–100 nm) with smaller
nanoparticles migrating to the emulsion interface and larger
nanoparticles aggregating in the pore wall. This is supported
by the TEM images and a recent study demonstrating the ef-
ficient self-assembly of nanoparticles in the range of 5–10nm
at polyHIPE pore walls.30,42 Recent scouting studies with
smaller MgOH nanoparticles (5–20 nm) in these polyHIPEs
have confirmed our hypothesis that smaller particles can self-
assemble and pack at the pore surface. Notably for this work,
alizarin red staining of calcium ions on polyHIPEs with ACP
and HA illustrated the presence of these particles at the surface
(Fig. 2B) and confirms the presentation of these minerals to
cells adhered to the polyHIPE. PFDMA films with ACP and
HA nanoparticles stained with alizarin red resulted in no
staining (Fig. 2A). It was hypothesized that the particles dis-
solved in the PFDMA macromer lack any thermodynamic
driving force to self-assemble at the film surface, unlike the
HIPE system where the change in hydrophobicities at the pore
wall promotes this self-assembly. Therefore, the negative
staining on the films compared to the positive staining on the
polyHIPEs illustrates the surface enrichment of these particles
in the polyHIPEs. The self-assembly of these particles at the
pore wall indicates the ability to incorporate a lower concen-
tration of bioactive particles while potentially maintaining
cellular response due to the increased surface area of particles
at the oil/water interface. Furthermore, polyHIPEs cultured in
growth media for 2 weeks exhibited a time-dependent depo-
sition of calcium on the surface of the scaffolds (Fig. 5B). This
increased calcium content potentially increases the overall
osteoinductivity of all polyHIPEs. Picrosirius red collagen
staining was utilized to locate DBM particles within the
polyHIPE. Because these particles were larger, visual in-
spection verified their incorporation. Positive staining of these
particles within the polyHIPE indicated that the DBMprotocol
maintained collagen-rich particles (Fig. 2C).
FIG. 1. Transmission electron
microscopy (TEM) micrographs of
(A) polyHIPE control and
(B) 5wt% HA polyHIPE show the
location of hydroxyapatite nano-
particles both at the pore surface
and aggregated within the
pore wall.
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Fabrication and pore characterization
of osteoinductive polyHIPEs
The goal of incorporating osteogenic elements into
PFDMA-based polyHIPEs was to confer an osteoinductive
character to the grafts without negative impact on the desir-
able graft properties such as injectability, porosity, and me-
chanical properties. First, the effect of ACP and HA
nanoparticles and DBM particles on pore architecture was
assessed. Figure 3 displays the effect of ACP, HA, and DBM
on pore architecture. A quantitative assessment of polyHIPE
pore size illustrated a negligible effect of ACP, HA, and
DBM on HIPE stability at concentrations analyzed as indi-
cated by statistically similar average pore sizes. The ability of
the HIPE to fill and cure around the larger DBM particles
with minimal gaps is demonstrated in Figure 4. In addition,
the maintenance of pore sizes surrounding the DBM particles
indicates a negligible effect of these particles on emulsion
stability. These results illustrate the ability to incorporate a
range of bioactive components to this polyHIPE stystem
without altering scaffold architecture.
Compressive properties of polyHIPEs with ACP,
HA, and DBM
A potential advantage of using porous PFDMA/BDMA
polyHIPEs for bone grafts is their rigid compressive prop-
erties. Therefore, it was important to assess the effect of the
bioactive agents on the graft compressive modulus and
strength. Figure 5 shows the ability to retain the compres-
sive modulus with the incorporation of all particles. These
results are further explained with the negligible change in
pore architecture, which greatly dictates monolith com-
pressive properties. A slight decrease in compressive
strength was observed with the incorporation of ACP, HA,
and DBM on polyHIPE, which may be attributed to regions
of aggregated particles that may result in stress concentra-
tors within the monolith Figure 1. The ability to incorporate
a variety of bioactive agents without affecting pore archi-
tecture and resulting compressive properties provides op-
portunity to design these polyHIPEs for a multitude of tissue
engineering applications. Furthermore, it may be possible to
modulate cell response in a dose-dependent manner by in-
corporating a range of concentrations of proteins and inor-
ganic minerals.
hMSC viability and proliferation
Illustrating the ability of these injectable polyHIPEs to
promote hMSC differentiation down an osteogenic pathway
is one of the major goals of this research. With this in mind,
initial verification of hMSC viability on polyHIPE sections
is crucial in moving forward with additional cell behav-
ior studies. Two week hMSC viability values after direct
FIG. 3. Representative scanning electron microscopy (SEM) micrographs of (A) polyHIPE control, (B) 2wt% amorphous
calcium phosphate (ACP), (C) 5wt% hydroxyapatite (HA), and (D) 15wt% demineralized bone matrix (DBM) (n = 450)
illustrate the effect of osteoinductive particles on pore architecture.
FIG. 2. Particle staining within polyHIPEs and films il-
lustrates the successful incorporation and relative location of
the respective particles. Alizarin red was used to stain for
calcium ions and picrosirius red used to stain collagen. (A)
Negative staining of alizarin red of HA nanoparticles in
propylene fumarate dimethacrylate (PFDMA) film indicates
minimal surface enrichment. (B) Alizarin red staining of
polyHIPEs cultured in growth media through 2 weeks. All
polyHIPEs stained positive for calcium after two weeks,
indicating the deposition of calcium from the media. (C)
Picrosirius red staining illustrating the collagen-rich DBM
particles in the polyHIPE. Color images available online at
www.liebertpub.com/tea
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culture on polyHIPEs with ACP, HA, and DBM are shown in
Figure 6A. All conditions promoted good viability through 2
weeks. Representative images of hMSCs seeded on all
polyHIPE compositions at weeks 1 and 2 are shown in
Supplementary Figure S1. An increase in cell viability was
seen with all bioactive agents compared to the PFDMA/
BDMA control at 1 week. PolyHIPEs with ACP, HA, and
DBM resulted in greater than 85% viability. This may be
attributed to increased cell–cell signaling with the calcium
and phosphate ions and enhanced integrin-binding sites from
the collagen in the DBM. In addition, the effect of particles on
hMSC proliferation is shown in Figure 6B. Proliferation
through 2 weeks was observed in all conditions with signif-
icant changes in the no particle control and HA polyHIPE
groups. Given the fact that it is difficult to promote desired
cellular behavior on synthetic materials, this evidence of cell
proliferation is promising for future advancements of this
material. Furthermore, stable methacrylate-based polyHIPEs
with 2wt%HA and 10wt%DBMwere fabricated illustrating
the potential to incorporate multiple bioactive agents to fur-
ther promote cell adhesion and proliferation. Future work
will focus on the effect of polyHIPEs containing both cal-
cium phosphate (various ratios of HA:ACP) and DBM to
determine whether there is a synergistic effect. These results
highlight the potential of these polyHIPEs to support cellular
adhesion and proliferation in vivo.
Gene expression of bone-specific markers
Gene expression was evaluated at 1 and 2 weeks to obtain a
snapshot of hMSC phenotype after culture on the polyHIPEs
as an early indication of osteogenic differentiation. Only the
calcium phosphate polyHIPEs were investigated within this
study as we focused on osteogenesis through calcium ion
stimulation. We hypothesized that the calcium phosphate
would stimulate osteogenic differentiation through free cal-
cium ions at a faster rate compared to the no particle con-
trol. In the time in which gene expression was sampled, all
polyHIPE groups promoted osteogenic gene expression as
measured by levels of early osteogenic factors (runx2 and
ALP) and later markers (OCN, Col1a1, and OPN) compared
to the initial day 0 readings (Fig. 7). As expected, runx2 and
ALP levels were generally higher in week 1 compared to
week 2. In contrast, OCN, Col1a1, and OPN expressions
were all elevated at week 2 compared to week 1. Notably,
expressions of these markers for all of the polyHIPEs in
growth media were comparable or greater than the control
polyHIPE cultured in osteogenic media. This indicates that
all compositions displayed an osteoinductive character, but
no differentiation between the compositions was observed.
There was no significant increase in expression of runx2,
ALP, OPN, Col1a1, or OCN from hMSCs on the polyHIPEs
with particles compared to the no particle control.
FIG. 5. Effect of osteoinductive particles on polyHIPE compressive modulus (A) and strength (B). *denotes the statistical
significance between polyHIPE control and polyHIPE with particles.
FIG. 4. SEM micrographs illus-
trate the incorporation of DBM
particles with minimal gap at the
interface between particle and
polyHIPE. Magnification at 500·
(A) and 4000· (B). PolyHIPE,
polymerization of high internal
phase emulsions.
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FIG. 6. Human mesenchymal stem cell (hMSC) viability and proliferation on osteoinductive polyHIPEs at 1 and 2 weeks.
(A) Viability as determined with calcein and ethidium homodimer-1 and (B) proliferation determined by DNA quantifi-
cation measured using a Quant–iT PicoGreen assay. The initial cell seeding density was 100,000 cells/cm2.
FIG. 7. Gene expression of early and later stage osteogenic markers in growth media and osteogenic media through 2
weeks relative to day 0. hMSCs were cultured on polyHIPEs with no particles, ACP, or HA in growth media (GM) and no
particle control polyHIPEs in osteogenic media (OM). (A) Runx2 and ALP expression, (B) osteopontin (OPN), collagen
type I (Col1a1), and osteocalcin (OCN) expression. * indicates significance between marked with an asterisk or all other
groups in the case where only one group is marked. o indicates significance between groups marked with the same symbol
(o). Color images available online at www.liebertpub.com/tea
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Multiple reasons may explain the similar osteogenic gene
expression profiles of hMSCs cultured on the no particle
controls compared to polyHIPEs with calcium phosphate
particles. The most probable reason is the deposition of
mineral from the growth media, which resulted in compara-
ble levels of calcium on all polyHIPEs. Figure 5B illustrates
positive calcium staining of control polyHIPEs cultured in
growth media through 2 weeks in the absence of cells and
shows similar stain intensity between all groups. It is prob-
able that the pH and temperature during culture on the
polyHIPEs promoted the deposition of calcium to achieve an
equilibrium ion concentration. In the body, the process of
calcification occurs when the solubility of interstitial calcium
is exceeded and is dictated by temperature and pH. Research
conducted on rat osteoclasts at pH values ranging from 6.9 to
7.4 indicated that a pH of 7.4 promoted the maximum cal-
cium deposition.43 Typical basal media are supplemented
with buffers to regulate the culture conditions between a pH
of 7.2 and 7.4 at 37C and 5% CO2. Thereby, these cell
culture conditions are ideal for mineralization in vitro. This
behavior has been seen on other poly(propylene fumarate)
(PPF)-based scaffolds with similar chemistries as PFDMA-
based polyHIPEs. Specifically, PPF 3D scaffolds have been
soaked in simulated body fluid to produce mineralized scaf-
folds,44 and PPF-based hydrogels incubated in culture me-
dia exhibited increased calcium deposition levels through
28 days in culture.45
This deposition of calcium on all polyHIPE compositions
may explain the comparable upregulation of bone-specific
genes from the seeded hMSCs. Calcium ions are a key reg-
ulator in osteoblast cell fate.46 Higher calcium ion levels are
known to stimulate a signaling cascade through the extra-
cellular calcium-sensing receptor, which promotes osteoblast
differentiation and inhibits osteoclast differentiation.47 Many
studies have investigated calcium deposition on collagen
matrices for tissue engineering applications. Maeno et al.
investigated the effect of various concentrations of calcium
ions in the media on the viability, proliferation, and differ-
entiation of osteoblasts encapsulated in collagen gels. They
concluded that 5mM of calcium ions in the media was op-
timal for cell survival and differentiation into mature osteo-
blasts.48 Studies conducted on collagen sponges in media
containing 1.6mM calcium illustrated minimal calcium de-
position on phosphate-free scaffolds compared to 10wt%
calcium deposition on sponges with phosphate indicating the
potential role of phosphates as a site of nucleation for min-
eralization.49 The basal media utilized in this study contain
1.8mM calcium plus the calcium found in the fetal bovine
serum supplemented to the media. Therefore, we would ex-
pect a substantial amount of calcium deposition on the
PFDMA-based polyHIPEs in these media conditions. In the
body, bone and sera contain 0.8–1.0 and 2.5mM calcium
ions, respectively.50 In the trabecular bone, 40wt% of the
tissue comprised calcium.51 Because calcium composes a
large fraction of the environment in which these injectable
polyHIPEs would be utilized, it is likely that mineral depo-
sition on polyHIPEs in vivo would favor osteogenic differ-
entiation of endogenous or encapsulated hMSCs. Ideally, the
concentration of calcium phosphate particles incorporated
into the polyHIPEs should also promote the deposition of
calcium and phosphate ions and enhance hMSC proliferation
and differentiation into osteoblasts. However, the high levels
of calcium deposition on the control polyHIPE without na-
noparticles likely obscured the effects of the nanoparticles
and the effect of different dissolution rates of the nano-
particles (HA vs. ACP). Thermal gravimetric analysis and
calcium colorimetric assays will be conducted in the future to
determine relative concentrations of mineral within the
polyHIPE samples to further elucidate dose-dependent ef-
fects on hMSC differentiation.
Furthermore, osteogenic differentiation stimulated through
soluble factors in the osteogenic media compared to material-
based cues from the no particle control polyHIPEs was
evaluated. Overall, there was no significant increase in bone-
specific gene expression from hMSCs in osteogenic media
compared to growth media. In contrast, ALP, OPN, and
OCN levels from hMSCs in osteogenic media were signif-
icantly lower than expression from cells in the growth media
at 2 weeks. This is most likely due to the nature of the test.
It is likely that the peak expression of these genes occurred
at an earlier time in osteogenic media and was not captured
at the time points analyzed. Further investigation should
include intermediate and longer time points to better map
the gene expression over time for each condition.52 Once
any differences in levels are determined using the altered
time points, a systematic study measuring gene expression
as a function of particle concentration will be completed.
The effect of DBM in the polyHIPE matrix on bone-specific
gene expression from hMSCs will also be investigated. Of
importance, at the time points we assessed, the expression in
normal growth media was comparable to osteogenic media
indicating the inherent osteoinductive character of the
polyHIPEs. This indicates the strong potential of these
grafts to enhance osteogenesis without the need for potent
growth factors.
Potential as injectable bone grafts
There has been ongoing research into injectable bone grafts
for a wide range of orthopaedic procedures from trauma
reconstruction to osteoporotic fracture stabilization.17,53 In-
jectable scaffolds that cure in situ can fill irregular-shaped
defects, enhance scaffold integration with the surrounding
tissue, and eliminate the need for costly molding techniques.
Current injectable materials are limited by a lack of porosity
and biodegradability (e.g., bone cements/putties) or inability
to withstand physiological loading (e.g., hydrogels/colloidal
gels). A highly porous scaffold that is injectable and cures in
situ to suitable mechanical strength represents a significant
advancement in bone grafting procedures. To this end, we
developed a biodegradable polyHIPE composition with rapid
in situ cure rates and compressive properties comparable to
the trabecular bone. We previously demonstrated that the
polyHIPE can effectively space-fill an irregularly shaped
defect and cure under physiological conditions (37C and
water) with microscale integration with the surrounding
bone.8 Notably, the redox initiation utilized in these grafts
does not require external stimuli to initiate crosslinking,
which can limit the size of constructs to the effective depth of
penetration. Despite these promising findings, there was no
confirmation that this newmaterial could support osteoblastic
differentiation of hMSCs before this study. This is a critical
determinant in the potential utility as bone grafts. Typically,
osteogenic differentiation of hMSCs either requires costly
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predifferentiation that delays treatment or controlled in vivo
release of growth factors such as BMP-2. Recent clinical
complications due to rapid and uncontrolled release of BMP-2
(e.g., ectopic bone growth, inflammation) have raised safety
concerns of this strategy.12,13 In contrast, the current study
demonstrated the ability tomodify the surface of the polyHIPE
through self-assembly of calcium phosphate nanoparticles at
the porewall without sacrificing desirable graft properties such
as injectability, pore architecture, or mechanical properties.
Several studies have demonstrated that the presentation of
mineral to hMSCs can induce osteogenic differentiation
without the negative side effects of supraphysiological levels
of growth factors.15,16 Unexpectedly, osteogenicmarkers were
upregulated in the polyHIPEs with and without the nano-
particles indicating that the base polyHIPE material had an
osteoinductive character.We hypothesized that this was due to
calcium deposition on the scaffolds from the media and that
this effect would translate to the in vivo scenario, given the
high levels of calcium in bone. A rat calvarial defect study is
currently underway to determine the impact of the observed
osteoinductive character of the polyHIPE material and any
additional benefits of the nanoparticles on osteogenesis. Al-
though the unique combination of properties of these poly-
HIPEs demonstrates the strong potential as bone grafts, future
studies will focus on broadening the pore size and tuning the
degradation profile to enhance bone regeneration. In the cur-
rent studies, a single architecture was investigated with a pore
size that is significantly smaller (*10mm) than the typically
accepted pore size that promotes cell infiltration and new bone
formation (100–400mm).54–56 However, we have previously
demonstrated that pore size of these injectable polyHIPEs
can be readily tuned by altering the stability of the emulsion
(surfactant concentration, aqueous phase volume fraction,
fabrication conditions) to achieve pore sizes greater than
100mm.7,8 Given that our current studies demonstrate that the
surface modification had minimal effect on pore size, we ex-
pect to be able to utilize this technique to modify polyHIPE
grafts with larger pores for investigation as bone grafts in
upcoming in vivo studies.
Conclusions
ACP, HA, and DBM particles were added to PFDMA-
based polyHIPEs to confer osteoinductive character and en-
hance bone regeneration. To this end, stable HIPEs with each
of these bioactive agents were formed with negligible change
in pore architecture and compressive properties. Initial hMSC
viability testing indicated that all polyHIPE conditions pro-
moted viable cells which proliferated over time on all com-
positions. Within these studies, we illustrated the inherent
ability of PFDMA-based injectable polyHIPEs to promote
osteogenic differentiation. Additional work must be done to
determine the relative amount of calcium deposition from the
media and calcium phosphate nanoparticle resorption rates
within the polyHIPE matrix to enhance hMSC osteogenesis.
Overall, this work demonstrates the ability to incorporate
a range of bioactive components into these injectable poly-
HIPEs to increase cellular interactions and direct specific
behavior without compromising scaffold architecture and
resulting properties. There is great translational potential for
these rigid porous polyHIPEs as a bone cement material to
enhance osseointegration and regeneration.
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